Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
| Status: | Completed |
|---|---|
| Conditions: | Alzheimer Disease |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 2/10/2017 |
| Start Date: | May 2014 |
| End Date: | December 2016 |
An Open Label, Multicenter Study, Evaluating the Imaging Characteristics of a Follow-up 18F-AV-1451 Scan in Subjects Who Have Had a Prior 18F-AV-1451 Scan
This study will evaluate the imaging characteristics of 18F-AV-1451 in subjects with a
previous 18F-AV-1451 scan in order to assess the rate of change of tau deposition over time.
previous 18F-AV-1451 scan in order to assess the rate of change of tau deposition over time.
Inclusion Criteria:
- Have a previous 18F-AV-1451 brain scan
- Can tolerate up to two Positron Emission Tomography (PET) imaging sessions and a
Magnetic Resonance Imaging (MRI) scan
- Ability to provide informed consent
Exclusion Criteria:
- Current clinically significant psychiatric disease
- Are claustrophobic
- Current clinically significant cardiovascular disease or ECG abnormalities, or
additional risk factors for Torsades de Pointes
- Current clinically significant infectious disease, endocrine or metabolic disease,
pulmonary, renal or hepatic impairment, or cancer
- Females of childbearing potential who are not surgically sterile, not refraining from
sexual activity or not using reliable methods of contraception
- Have had a non-study related radiopharmaceutical imaging or treatment procedure
within 7 days prior to the study imaging session
We found this trial at
4
sites
St. Louis, Missouri 63110
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials